ReviewCureus2025
Racial Disparities in Clinical and Cost Outcomes Among Heart Transplant and Left Ventricular Assist Device Recipients: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although racial disparities in cardiac interventions have been studied extensively, disparities in heart transplants (HTs) and left ventricular assist devices (LVADs) have not been well-established. A systematic review was undertaken wherein 20 studies were identified for investigation, with a total of 785,486 patients. Of these, 104,356 patients were studied to assess HT and LVAD access, 332,885 patients were studied to assess in-hospital mortality rate, 346,303 patients were studied to assess organ function, and 1,942 patients were studied to assess costs associated with HT or LVAD treatment among different racial groups. Access was evaluated via the percentage of patient race within each study's population. White patients received the majority of LVADs (44,248 patients, 63.34%) and HTs (21,273 patients, 61.67%), followed by Black patients for LVADs (16,437 patients, 23.53%) and HTs (7,603 patients, 22.04%). Hispanic/Latino patients had the lowest rates of LVADs (4,071 patients, 5.83%) and HTs (3,153 patients, 9.14%). Asian patients had the highest in-hospital mortality (4,104 patients, 39.2%), whereas White patients had the lowest (84,977 patients, 36.2%). Results of cost outcomes varied, with Asian patients having the highest mean cost and Black patients having the lowest mean cost for transplantation. Racial disparities in HTs and LVADs were noted, highlighting the need for multi-faceted approaches to provide equitable access and improved outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.